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Principle component analysis (PCA) and a two-way analysis of variance (ANOVA) were employed in the 
study of factors affecting extractability of benzimidazole anthelmintics using supported liquid 
membrane (SLM) in liver, kidney, milk and urine at four concentration levels. The SLM extraction 
process was monitored by liquid chromatography - mass spectrometer (LC-MS). The results showed 
that the extractability of benzimidazoles is dependent on both the concentration levels and the chemical 
properties of compounds. Based on chemical properties, extraction of the compounds from the liver 
matrix showed no significant difference (p = 0.05) for the following pairs; albendazole and oxibendazole, 
thiabendazole and mebendazole, oxibendazole and fenbendazole, and oxibendazole and mebendazole. 
At some of the concentration levels, mainly between 1000 and 100, 100 and 10, and 10 and 1 µg/Kg, 
there was no significant difference. It was also found that, there was significant difference (at p = 0.05) 
in the extractability in milk between oxibendazole and albendazole, and also oxibendazole and 
fenbendazole. For milk also, the concentration range from 10 to 100 µg/L, showed no significant 
difference (p = 0.05). Urine matrix on the other hand, showed significant difference in the recoveries at 
all concentration levels. 
 
Key words: Benzimidazoles, supported liquid membrane (SLM), liquid chromatography-mass spectrometry 
(LC-MS), two-way analysis of variance (ANOVA), principle component analysis (PCA). 
 
 
INTRODUCTION 
 
The use of antibiotics and antibacterial in animal 
husbandry has been in practice for decades (Gustafson, 
1986). Benzimidazole anthelmintics together with a 
number of other similar compounds are used or abused 
in animal husbandry mainly as growth promoters, 
prophylactics and chemotherapeutic agents (Msagati and 
Nindi, 2001; Msagati and Ngila, 2003; Msagati, 2005; 
Msagati and Nindi, 2006). The widespread use of these 
antibiotics has resulted in the potential adverse effects to 
human health, due to consumption of contaminated 
foodstuffs of animal origin. Moreover, parent drug 
molecules or their  metabolic  degradation  products  may 
 
 
 
*Corresponding author: E-mail: tmsagati@uj.ac.za. Tel: +27 11 
559 6209. Fax: +27 11 559 6425. 
directly or indirectly find their way to the environment, 
through wastewater coming from shelters where treated 
animals reside. This may result in the contamination of 
waters in streams, as well as in wastewater treatment 
plants and thus cause adverse effect on the microbial 
ecosystem responsible for degradation of complex 
organic materials. 
Normally, the drug molecules interact chemically with 
molecules in the environment where they are being 
disposed off. The occurrence and significance of the 
interaction between antibiotic residues and matrix 
molecules have been of interest to analytical chemists 
who are responsible for developing chemical methods 
capable of effective sample clean up from different 
matrices of either biological or environmental origin 
(Msagati and Nindi, 2006). Several methods utilizing 
different  strategies to isolate benzimidazole anthelmintic,  
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mainly those involving the use of solid phase extraction, 
have been reported (Nerenberg et al., 1982; Michiels et 
al., 1982; Bushway et al., 1990). Bradon and coworkers 
reported a method utilizing a combination of liquid-liquid 
extraction and SPE for the extraction of benzimidazole 
compounds (Bradon et al., 1990). Our research group 
reported successful use of supported liquid membrane 
(SLM) to extract benzimidazole anthelmintic compounds 
from a variety of biomatrices (Msagati and Nindi, 2001; 
Msagati and Ngila, 2003; Msagati, 2005; Msagati and 
Nindi, 2006). Analytical techniques for detection of these 
compounds after sample treatment (using SLM, SPE, 
LLE, etc) include ELISA (Horton, 1990) and 
immunoassay (Newsome and Collins, 1987; Barker et al., 
1986) electrochemical (Msagati and Ngila, 2003; Struck 
and Elving, 1964; Passet and Tsivina, 1972; Smola and 
Sontag, 1985; McClean et al., 1994), liquid 
chromatography (Msagati and Nindi, 2001; Rose, 1999; 
Hajee and Haagsma, 1996; Steenbaar et al., 1993; Al-
Kurdi et al., 1999) and liquid chromatography coupled to 
mass spectrometry (LC-MS) (Msagati and Nindi, 2006; 
De Ruyck et al., 2001 and Balizs, 1999). 
In spite of good intentions of using established sample 
pretreatment strategies to achieve effective and efficient 
extractability, the effect of interactions of variables that 
impact on the extractability of analytes from biomatrices, 
cannot be ignored. The practice in the investigation of the 
interaction between antibiotic residue and matrix 
molecules is to use a classical approach that involves 
varying one parameter while keeping all other variables 
constant (Saltzman and Yaron, 1986). However, this 
approach has limitations in that, it cannot provide the 
information on how variables interact in synergistic or 
antagonistic way. 
In this study, we have employed both PCA and a two-
way ANOVA which is a statistical technique that can 
establish the nature of interactions of variables that affect 
the response signal during the determination of the 
analytes, in this case, benzimidazole anthelmintics 
(Figure 1). Using ANOVA, experiments were performed 
which allow the flexibility of having independent variables 
modified. 
 
 
Design for PCA test model 
 
With PCA analysis, the data was obtained by computing the 
eigenvalues and eigenvectors of the covariance matrix, such that it 
was possible to get the original variables and the principal 
component scores, using equations obtained from a number of 
PCA equations, e.g. principal component 1(Prin1) and 
principalcomponent 2 (Prin2) which are the new variables or linear 
combinations and the original mean-corrected variables (x1 and 
x2). The PCA equations were formulated as follows: 
 
ξ1 = Prin1 = V1x1 + V2x2                                                              (1) 
 
ξ2 = Prin2 = -V2x1+ V1x2                                                              (2) 
 
 
 
 
Where the sum of squared weights of each component is unity, that 
is (V1)2 + (V2)2 = 1 and also (-V2)2 + V12 = 1, on the other hand, 
the sum of the cross products of the weights is zero, that is, [V1 x – 
(V2) + V2 x V1)] = 0. 
 
 
Design for a two-way ANOVA test model 
 
A statistical model was designed to provide an optimal method for 
investigation of the relationship between response (Y) and control 
variables (i, j, k). If (Yijk) is a response signal related to the recovery 
in the form of extraction efficiency of the SLM, while αi and βj 
denotes concentration levels and compounds fortified in matrices 
respectively. Using a set of control variables in each case 
represented by i, j and k, we can then propose a functional 
relationship (mathematical model) which gives Yijk as a function of 
αi and βj. 
 [ ]ijkjiijk fY αββα ++=
                                                       (3) 
 
The overall form of the model being tested in this study is as 
follows: 
 
ijkijjiijk eY ++++= αββαµ
                                 (4) 
 
where; ijk
Y
 is the 
thk recovery efficiency resulting from the ith 
concentration level and the jth compound; µ  is a constant; α is the 
effect of the ith level of concentration in a given matrix; β is the 
effect of the jth level of compound in the same matrix; αβ is the 
interaction between the ith level of concentration in a given matrix 
and jth level of benzimidazole compound in the same matrix; and e 
is the error function (uncertainty) associated with the observation Y 
Thus, the two chemometric techniques (PCA and ANOVA) were 
used to reveal the nature of interactions between benzimidazole 
compounds and matrix components, that is, establishment of 
whether the effect of interaction is additive or parallel and hence the 
impact of these interactions on the extractability and hence limit of 
quantification of the benzimidazole compounds in various 
biomatrices. 
 
 
EXPERIMENTAL 
 
Benzimidazole anthelmintics 
 
The benzimidazole anthelmintics (albendazole, fenbendazole, 
mebendazole, oxibendazole and thiabendazole) were from Sigma 
(St. Louis, USA). The standard stock solutions were prepared by 
dissolving ~1 mg of benzimidazole compound in 1 ml of the solvent 
comprising of 1:1, v/v of methanol and formic acid in water (95:5, 
v/v) to give a final solution concentration of 1000 mg/L. The 
structures and molecular weights of the benzimidazole 
anthelmintics compounds studied are shown in Figure 1. 
 
 
SLM procedure 
 
SLM was used in this work for the extraction of benzimidazoles 
from a variety of biological matrices and the extracts were detected 
using LC-MS. SLM involve a three phase system (Msagati and 
Nindi, 2001; Msagati and Ngila, 2003). An aqueous sample phase 
(feed/donor) is separated from an aqueous receiver (acceptor) 
phase  by  a  layer  of  organic  solvent  impregnated  in  the porous  
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  Figure 1. Structures and molecular weights of benzimidazole anthelmintics studied. 
 
 
 
membrane. In order to enhance extractability and selectivity of 
solutes in SLM, the conditions (sample pH, extraction time and flow 
rate) in the aqueous sample phase were adjusted such that the 
analyte of interest is forward-extracted out of the sample phase into 
the organic phase and back-extracted out of the organic phase into 
the receiver phase, in a concerted fashion (Msagati and Nindi, 
2001; Msagati and Ngila, 2003; Msagati, 2005; Msagati and Nindi, 
2006). The SLM experiment in this work incorporated a chemical 
extractant or a carrier (tri-n-octylphosphine oxide – TOPO) to 
enhance the process of selective transport of analyte components 
across the membrane interface. The extracts were determined by 
LC-MS. 
 
 
RESULTS AND DISCUSSION 
 
The results and discussion given here is restricted to 
PCA and ANOVA studies and no attempt shall be made 
to discuss data obtained with SLM/LC-MS, as we have 
previously   reported   them   (Msagati   and  Nindi,  2001; 
Msagati, 2005; Msagati and Nindi, 2006). In this paper, 
PCA and a two-way analysis of variance (ANOVA) were 
applied, as they provide an efficient evaluation for all the 
observed behaviour during the SLM process of 
benzimidazoles, in a variety of biomatrices at different 
concentration levels. The principal component analysis 
has been instrumental in scaling down (compress) the 
data, in order to understand better, how various factors 
interact. 
 
 
Inter-matrix variation studies 
 
PCA studies of the SLM extractability of 
benzimidazole anthelmintics from liver tissues 
 
The PCA analyses of the extractability of various 
benzimidazole   compounds   in   the   liver    matrix    has  
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Figure 2a. PCA of benzimidazole’s physico-chemical properties influence on the SLM extractability of the 
compounds in the liver. 
 
 
 
revealed that, albendazole and thiabendazole interact 
with the components of this matrix in more or less the 
same way. Thiabendazole seems to be interacting 
differently from all other benzimidazole anthelmintics 
studied. Structurally, the compounds (except 
thiabendazole) (Figure 1) contain the same side chain, 
joining the imidazolium ring (NH-CO-OCH3); presumably, 
this is the functional group responsible for the interaction 
with the molecules found in the liver matrix. Alternatively, 
the similarity in terms of their extractability may be based 
on the fact that, the vast chemistries in the liver matrix 
offer similar kinds of interaction to these compounds and 
at the same magnitude, hence affect their extractability in 
a similar proportion. 
However, the effect of the concentration levels (cll-
benzimidazol) was found to be more pronounced than the 
effect of the physico-chemical properties of the 
compounds (cpl-benzimidazol) (Figures 2b and c). The 
more pronounced effect of concentration levels in the 
liver matrix as compared to the effect of chemical 
properties, might be attributed to the saturation of the 
active sites for binding within the matrix, such that at a 
certain   level  of  concentration, these  active  sites  were 
exhausted and therefore easier to extract as the drug 
molecules were in free forms (unbound). Before the 
saturation of the active sites in the matrix, there exist a 
competition between the matrix molecules and the 
organic membrane for the drug molecules, but in the 
absence of competition, all the free drug molecules will 
tend to cross the organic membrane and be trapped in 
the stagnant acceptor. 
 
 
PCA studies of the SLM extractability of 
benzimidazole anthelmintics from kidney tissues and 
urine 
 
The results of the extraction of benzimidazole 
anthelmintics from kidney tissues show a similar pattern 
as that for liver in that, only thiabendazole displayed a 
different behaviour (Figure 3a). The explanation for this 
similarity is that, there is commonality in terms of 
chemical properties (Figure 1) in that, thiabendazole with 
no side chain interacts differently from other 
benzimidazole compounds in the same matrices and 
hence  different  extractability  trend.  However,  in   urine  
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Figure 2b. PCA of combined benzimidazole’s physico-chemical properties and concentration 
levels’ influence on the SLM extractability of the compounds in the liver. 
 
 
 
 
 
Figure 2c. PCA scores for the combined benzimidazole’s physico-chemical properties and 
concentration levels’ influence on the SLM extractability of the compounds in the liver. 
 
 
 
matrix, both the chemical properties and levels of 
concentrations seem to affect weakly the extractability of 
the compounds (Figures 3b and c); with the kidney 
matrix, there is commonality in terms of chemical 
properties between fenbendazole and oxibendazole, as 
they seem to interact the same way with milk matrix as 
they show similar extractability trend. The same can be 
concluded  for  albendazole  and  mebendazole; with  the 
kidney matrix also, both the chemical properties and 
levels of concentration affects weakly and therefore, have 
little influence on the extractability of the compounds. 
PCA studies of the SLM extractability of benzimidazole 
anthelmintics from milk PCA results for benzimidazoles in 
the milk matrix indicated poor extractability for all the 
compounds. This may be due to the complex nature of 
the   milk   matrix   itself,   as   it   is   composed   of   very 
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Figure 3a. PCA of benzimidazole’s physico-chemical properties influence on the SLM 
extractability of the compounds in kidney tissues. 
 
 
 
hydrophobic molecules, such as fats and lipids, which 
complicate tremendously to the difficulties in the SLM 
extraction process of benzimidazole anthelmintic 
compounds 2-5. 
 
 
Inter-analyte variation 
 
Analysis of variance (ANOVA) studies of the SLM 
extractability of benzimidazole anthelmintics from 
various matrices 
 
A two way-ANOVA enabled the efficient evaluation of 
whether different concentration levels affect the efficiency 
of supported liquid membrane performance, that is, the 
extractability of benzimidazole compounds for a particular 
matrix under study. It also allowed the evaluation of 
whether the nature (chemical properties) of different 
compounds behaved differently as they diffused across 
the hydrophobic membrane during extraction when 
concentration levels, were held constant or varied. The 
results of the ANOVA tests on the extractability of 
benzimidazole compounds across the supported liquid 
membrane are shown in Tables 1 to 3. The results are in 
agreement with the test proposed model (in Equations 3 
and 4). 
Two-way ANOVA studies of the SLM extractability of 
benzimidazole anthelmintics from liver tissues 
 
The results in Table 1 show that the proposed model 
(defined in Equations 1 and 2) is suitable in describing 
the relationship between the extraction efficiency, the 
nature of compounds and concentration levels (P < 0.05). 
Furthermore, there is a significant difference between the 
concentration levels and the compounds at p < 0.05, as 
well as a significant interaction between concentration 
levels and compounds. 
In order to determine which compounds are 
significantly different from each other in terms of their 
extractability in the supported liquid membrane, the least 
square difference (LSD) which is, a multiple comparison 
test, was carried out. The results (Table 2) reveal that 
thiabendazole is significantly different from all the other 
compounds (P < 0.05), with the exception of 
mebendazole. Further, it was observed that, there was no 
difference between oxibendazole and fenbendazole; 
fenbendazole and mebendazole, implying that any of 
these compounds could have been used to give the 
same extraction efficiency. 
Table 3 shows the multiple comparison tests for the 
concentration levels, whereby all the concentration levels 
are  significantly different from each other (P < 0.05). This  
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Figure 3b. PCA of combined benzimidazole’s physico-chemical properties and 
concentration levels’ influence on the SLM extractability of the compounds in urine. 
 
 
 
 
 
Figure 3c. PCA scores for the combined benzimidazole’s physico-chemical properties 
and concentration levels’ influence on the SLM extractability of the compounds in urine. 
 
 
 
Table 1. Tests of between-subjects effects in the SLM extraction of benzimidazoles from liver tissues. Dependent variable: 
concentrations in spiked liver. 
 
Source Type III sum of squares df Mean square F Sig. 
Corrected model 13935.594a 24 580.650 9.256 0.000 
Intercept 669033.568 1 669033.568 10664.663 0.000 
β benzimidazoles liver 4467.361 4 1116.840 17.803 0.000 
α benzimidazoles liver 7000.454 4 1750.113 27.898 0.000 
αβ benzimidazoles liver * benzimidazoles liver 2467.779 16 154.236 2.459 0.004 
Error 6273.368 100 62.734   
Total 689242.530 125    
Corrected total 20208.962 124    
 
R2= 0.690 (adjusted R2 = 0.615).  
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Table 2. Multiple comparisons within and between benzimidazole compounds extracted from liver tissues at 95% level of 
confidence using Least Square Difference (LSD) approach. 
 
(I) Benzimidazoles  (J) Benzimidazoles  Mean difference (I-J) Std. error Sig. 95% CI 
Lower  Upper  
Thiabendazole 
  
Oxibendazole 10.0680(*) 2.24024 0.000 5.6234 14.5126 
Mebendazole 2.1280 2.24024 0.344 -2.3166 6.5726 
Albendazole -7.6120(*) 2.24024 0.001 -12.0566 -3.1674 
Fenbendazole 6.1600(*) 2.24024 0.007 1.7154 10.6046 
       
Oxibendazole 
    
Thiabendazole -10.0680(*) 2.24024 0.000 -14.5126 -5.6234 
Mebendazole -7.9400(*) 2.24024 0.001 -12.3846 -3.4954 
Albendazole -17.6800(*) 2.24024 0.000 -22.1246 -13.2354 
Fenbendazole -3.9080 2.24024 0.084 -8.3526 0.5366 
       
Mebendazole 
    
Thiabendazole -2.1280 2.24024 0.344 -6.5726 2.3166 
Oxibendazole 7.9400(*) 2.24024 0.001 3.4954 12.3846 
Albendazole -9.7400(*) 2.24024 0.000 -14.1846 -5.2954 
Fenbendazole 4.0320 2.24024 0.075 -0.4126 8.4766 
       
Albendazole 
    
Thiabendazole 7.6120(*) 2.24024 0.001 3.1674 12.0566 
Oxibendazole 17.6800(*) 2.24024 0.000 13.2354 22.1246 
Mebendazole 9.7400(*) 2.24024 0.000 5.2954 14.1846 
Fenbendazole 13.7720(*) 2.24024 0.000 9.3274 18.2166 
       
Fenbendazole 
    
Thiabendazole -6.1600(*) 2.24024 0.007 -10.6046 -1.7154 
Oxibendazole 3.9080 2.24024 0.084 -0.5366 8.3526 
Mebendazole -4.0320 2.24024 0.075 -8.4766 0.4126 
Albendazole -13.7720(*) 2.24024 0.000 -18.2166 -9.3274 
 
Based on observed means. * The mean difference is significant at the 0.05 level. 
 
 
 
Table 3. Multiple comparisons within and between various concentration levels in SLM extraction of benzimidazole compounds 
from liver tissues at 95% level of confidence using Least Square Difference (LSD) approach. 
 
(I) Conc. level for 
liver (µg/L) 
(J) Conc. level for 
liver (µg/L) 
Mean difference  
(I-J) Std. error Sig. 
95% CI 
Lower  Upper  
1000 
100 -6.0000(*) 2.24024 0.009 -10.4446 -1.5554 
10 -11.0840(*) 2.24024 0.000 -15.5286 -6.6394 
1 -16.3400(*) 2.24024 0.000 -20.7846 -11.8954 
0.1 -21.2720(*) 2.24024 0.000 -25.7166 -16.8274 
       
100 
1000 6.0000(*) 2.24024 0.009 1.5554 10.4446 
10 -5.0840(*) 2.24024 0.025 -9.5286 -0.6394 
1 -10.3400(*) 2.24024 0.000 -14.7846 -5.8954 
 0.1 -15.2720(*) 2.24024 0.000 -19.7166 -10.8274 
       
10 
1000 11.0840(*) 2.24024 0.000 6.6394 15.5286 
100 5.0840(*) 2.24024 0.025 0.6394 9.5286 
1 -5.2560(*) 2.24024 0.021 -9.7006 -0.8114 
0.1 -10.1880(*) 2.24024 0.000 -14.6326 -5.7434 
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Table 3. Contd. 
 
1 
1000 16.3400(*) 2.24024 0.000 11.8954 20.7846 
100 10.3400(*) 2.24024 0.000 5.8954 14.7846 
10 5.2560(*) 2.24024 0.021 0.8114 9.7006 
0.1 -4.9320(*) 2.24024 0.030 -9.3766 -0.4874 
       
0.1 
1000 21.2720(*) 2.24024 0.000 16.8274 25.7166 
100 15.2720(*) 2.24024 0.000 10.8274 19.7166 
10 10.1880(*) 2.24024 0.000 5.7434 14.6326 
1 4.9320(*) 2.24024 0.030 0.4874 9.3766 
 
Based on observed means. * The mean difference is significant at the 0.05 level.  
 
 
 
may be attributed to the fact that, the stripping solution 
(acceptor solution) which was used to entrap the 
compounds after they had diffused across the supported 
liquid membrane, was stagnant and hence, was subject 
to saturation by higher concentrations. Moreover, the 
compounds differ in their ionizability (different pKa 
values). This property is important when optimizing the 
pH of donor and acceptor pH. 
 
 
Two-way ANOVA for the SLM extractability of 
benzimidazole anthelmintics from kidney tissues 
 
The results of a two-way ANOVA analysis for the SLM 
extractability of benzimidazoles from the kidney tissues 
showed that, there was significant difference at 95% 
confidence level (p = 0.05) for all the compounds with an 
exception of albendazole and fenbendazole which 
showed similar extractability properties. The two 
compounds differ in the structures of their side chain, in 
which the albendazole has a propyl group attached to the 
sulfur atom, whereas in fenbendazole, it is a benzene 
ring. This difference in chemical functionality might have 
influenced their ability to cross through the hydrophobic 
membrane, as well as their extractability behavior, 
towards the stripping solution applied for these two 
compounds; with regard to the effect of concentration 
levels, a two-way ANOVA showed that there was 
significant difference at all concentrations, except 
between 100 and 1000 µg/Kg, as well as between 1 and 
10 µg/Kg. This could have been caused by the carry over 
effects during the extraction process, which may cause 
the analyte leftovers from previous enrichment to be 
carried over into the subsequent experimental run. Thus, 
carry over effects will render 100 µg/Kg to behave as 
1000 µg/Kg and 1 µg/Kg as 10 µg/Kg. 
 
 
Two-way ANOVA for the extractability of 
benzimidazole anthelmintics from milk 
 
The results from milk matrix showed that there was 
significant   difference   between    the    extractability    of 
oxibendazole and albendazole and also between 
oxibendazole and fenbendazole. The pKa values which 
are an indication of their ionizability may be responsible 
for the trend observed. The pKa value for albendazole is 
2.80, while those of fenbedazole and oxibendazole are 
between 5 and 6. It is worth noting that the compounds 
that ionize well usually extract better using liquid 
membranes. The effect of concentration levels on the 
extractability of benzimidazoles from milk samples, 
showed significant difference at 95% confidence limit 
(CL) for extraction at 10 and 100 µg/L. This again could 
be the consequence of carryover effects during 
theextraction process. 
 
 
Two-way ANOVA scheme studies of the extractability 
of benzimidazole anthelmintics from the urine matrix 
 
The general trend of extractability of the benzimidazole 
compounds in urine matrix showed significant difference 
at 95% confidence level for all the compounds at different 
concentration levels, except for thiabendazole. The 
nature of substituent bonding to the thiazolidine and 
imidazolium rings may account for this, since these are 
the only two compounds in which C atom is connected to 
a C atom in the thiazolidine ring of the benzimidazole 
structure. In the other compounds studied, N atom is 
bonded to the thiazolidine ring. 
 
 
Conclusions 
 
In this study, it was shown that, the ease of extractability 
of benzimidazole anthelmintic compounds using SLM 
was greatest for urine, followed by liver, then kidney and 
lastly milk. This study has also demonstrated the 
potential of multivariate principal component analysis 
(PCA) and a two-way ANOVA in predicting the 
optimization of crucial parameters mostly chemical 
properties and concentration level for the extractablity of 
benzimidazole anthelmitics. A two-way ANOVA has 
indicated that at 95% confidence level, the ionizability of 
compounds   (exemplified   by   the   pKa and pH values),  
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concentration level and the chemistry of the matrix 
strongly influence the extractability of benzimidazole 
compounds using supported liquid membrane. The 
bonding of the substituent groups such as C-N or C-C 
proved to be significant (CL 0.05) in the extraction of 
benzimidazoles in urine matrix. Complex matrix such as 
milk significantly (CL 0.05) affected the extractability of 
benzimidazoles, due to its strong interaction with analyte 
molecules. Furthermore, PCA has shown how various 
factors come into play to influence the extraction process. 
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